Lizmo-600

When Infections Become THREAT to Life

Novel Antibiotic Active Against Serious Infections

Zirucef-500

Overview

  • Treats Gram +ve infections and does not cause any life-threatening adverse effects1
  • Orally bioavailability of linezolid is comparable with intravenous administration2
  • More effective than vancomycin for the treatment of skin & soft tissue infections3
  • Well tolerated & shortens recovery period than vancomycin in nosocomial pneumonia4
  • Oral absorption is not affected by the co-administration of antacids5
Indications
  • Vancomycin resistant enterococcal infections
  • Methicillin-Resistant staphylococcus infections
  • Nosocomial pneumonia
  • Community acquired pneumonia
  • Skin & skin structure infections
  • Diabetic foot infections
Composition

Linezolid Tablets I.P. 600mg Tablets

Dosage

Twice daily

Packaging

Blister packs (10 tablets per strip)

AHS Banner